Statnews

Published October 16, 2026

RevMed's pancreatic cancer drug nears European approval - Stat News

Read the full story at Statnews

biotech , biotechnology , drug development, Drug prices, FDA, Pharmaceuticals, research ... Compass Pathways CEO: Psychedelics company will 'go.